Novo and Roche launch new treatment to simplify insulin pump therapy
Novo Nordisk has launched NovoRapid® PumpCart®, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps.
This new treatment solution, which contains NovoRapid® (insulin aspart) – a rapid-acting insulin from Novo Nordisk – is expected to make insulin pump therapy more convenient for people with diabetes and their healthcare professionals.
The 1.6 ml cartridge has been developed in a non-exclusive partnership between Roche Diabetes Care and Novo Nordisk and is compatible with the new Accu-Chek® Insight insulin pump therapy system from Roche Diabetes Care.
Dr Parth Narendran, clinical senior lecturer and honorary consultant in medicine at the University of Birmingham, said: “One of the challenges in operating a traditional pump lies in the manual filling of the insulin reservoir, a procedure with multiple steps, which can often be perceived as a complex and time-consuming process by patients and healthcare professionals alike.
deliver tangible benefits for those patients who rely on insulin pump therapy
“This can be a difficult hurdle to overcome when starting on insulin pump therapy, and is exacerbated by the extensive amount of time needed by healthcare staff to provide the necessary support during pump initiation. A simpler process could address this issue and deliver tangible benefits for those patients who rely on insulin pump therapy every day to manage their diabetes.”
Compared to multiple daily injections, insulin pumps can provide greater flexibility of lifestyle and potentially tighter blood glucose control without an increased risk of hypoglycaemia.
Dr Mark Evans, lecturer and honorary consultant in medicine at the University of Cambridge, said: “This can provide benefits to certain patients. In Europe, we’ve seen a slow but steady increase in insulin pump therapy uptake in recent years, but there is still room for improvement; in the United Kingdom pumps are currently used by 19 per cent of children and six per cent of adults with Type 1 diabetes.”
NovoRapid® PumpCart® was launched in the UK, Sweden and Austria on Monday, November 3, and will be made available in more European countries throughout 2015 and 2016. The Accu- Chek® Insight insulin pump therapy system has been launched in Austria in the first half of this year and was launched in the UK on Monday, November 3, with other European markets following throughout 2015.
This is so encouraging to observe that companies aren’t shying away from innovating for healthcare, despite the challenges. Very proud to be a part of the movement to improve lives of diabetics with My Dario… We are focusing on simplifying measuring of glucose level… with a smart meter connected to a smartphone! We’ve got some great feedback so far and seeing others in industry succeeding is a great motivation to keep going.
http://mydario.co.uk/solution/